CD163 and endometrial cancer: In addition, we found that low-grade endometrial cancer-draining LNs showed lower S100A/S100B MDSCs and CD163 macrophages than high-grade tumors, with no other significant differences, suggesting a more immunocompetent LN milieu in low-grade tumors.